Exscientia to Report First Quarter 2023 Financial Results on May 24, 2023
Exscientia plc (Nasdaq: EXAI) will report financial results for the first quarter ended March 31, 2023, on Wednesday, May 24, 2023, before the open of U.S. markets. The Company will host a conference call and webcast at 1:30 p.m. BST / 8:30 a.m. EDT to provide a business update and review financial results.
A webcast of the live call can be accessed by visiting the “Investors and Media” section of the Company’s website at investors.exscientia.ai. Alternatively, the live conference call can be accessed by dialing +1 (888) 330 3292 (U.S.), +44 203 433 3846 (U.K.), +1 (646) 960 0857 (International) and entering the conference ID: 8333895. A replay will be available for 90 days under "Events and Presentations” in the “Investors and Media” section of the Exscientia website.
About Exscientia
Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.
Visit us at https://www.exscientia.ai or follow us on Twitter @exscientiaAI.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230517005202/en/
Contact information
Investor Relations Contact:
Sara Sherman
investors@exscientia.ai
Media Contact:
Oliver Stohlmann
media@exscientia.ai
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities20.1.2026 15:30:00 EET | Press release
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has achieved College of American Pathologists (CAP) accreditation. This milestone builds on the site’s Clinical Laboratory Improvement Amendments (CLIA) certification, obtained in July 2025, further strengthening its ability to deliver clinical-grade biomarker testing to support regulated drug development programs. CAP accreditation is recognized as a leading benchmark for laboratory quality, reflecting rigorous standards for operational excellence, technical competence, and quality oversight. Together with CLIA certification—regulated by the U.S. Centers for Medicare & Medicaid Services—these credentials confirm the San Diego laboratory’s compliance with federal requirements for clinical testing on human specimens and its readiness to support biomarker analyses aligned with clinical trial and regulatory expectations. “Achieving CAP accreditatio
Leon and SkyAccess Announce Official Integration to Automate Empty Leg Listings for Charter Operators Across Europe20.1.2026 15:24:00 EET | Press release
SkyAccess, a real-time empty leg flight marketplace that aggregates private jet repositioning flights from a network of certified operators, and Leon Software, a cloud-based aviation management software platform used by charter operators worldwide, today announced an official integration that enables Leon charter operators to automatically list eligible empty leg and repositioning flights on the SkyAccess empty-leg marketplace. Meeting Growing Demand for Empty Leg Flights in Europe The announcement comes as interest in empty leg flights continues to grow across Europe, particularly on short-haul routes between major business and leisure hubs. Travelers are increasingly seeking flexible, one-way private jet options and more transparent access to repositioning flights. “Empty legs move quickly, and speed matters,” said Paweł Szmagaj, CTO of Leon Software. “With the Leon Software–SkyAccess integration, operators can share up-to-date availability with the market faster, while maintaining f
Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral Health20.1.2026 15:00:00 EET | Press release
Today, Colgate-Palmolive announced a new multi-year collaboration with the WHO Foundation to support the World Health Organization's work on oral health. The four-year funding commitment will help expand oral health education, support integration of oral health into national health systems, and raise awareness of oral health as a public health priority. This initiative builds on Colgate’s commitment to providing communities with oral health education and resources. The Company recently announced that the Colgate Bright Smiles, Bright Futures® program has reached approximately two billion children and their families around the world since 1991 with oral health education. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120050760/en/ “At Colgate-Palmolive, we are driven by our purpose to reimagine a healthier future for all – and to make more smiles. We’re launching this collaboration with the WHO Foundation given its unique
FGS Global Launches AI Advisory Practice and Acquires Threat Intelligence Firm Memetica20.1.2026 15:00:00 EET | Press release
FGS Global, the world's leading stakeholder strategy firm, today announced the launch of its AI Advisory practice and the acquisition of Memetica, a specialist technology consultancy in AI-driven threat detection and mitigation across social, dark web and fringe platforms. The new practice sits within FGS Global's recently formed AI and Innovation group led by Aaron Kwittken, Global Head of AI and Innovation. The AI Advisory practice builds on and consolidates FGS Global's deliberate, years-long investment in AI capabilities to support surging client demand for strategic and practical guidance on leveraging AI and emerging technologies to enhance communications efficacy, reputational defense and operational efficiencies. This critical work is supported by a global team of more than 200 strategists, analysts, engineers, developers, designers and data scientists across AI strategy, digital influence, campaigns, earned, paid and owned media, influencer engagement, special situations and c
CAS IP Finder Expands Intellectual Property Search Access Across Organizations20.1.2026 15:00:00 EET | Press release
CAS, a division of the American Chemical Society specializing in scientific knowledge management, announces complete functionality for CAS IP Finder™, powered by STN™. CAS STNext® customers can now access the full intellectual property search solution across all search methods, expanded content collections, and advanced analysis tools. Patent volume continues to grow, and scientific disciplines are increasingly interconnected, making intellectual property research more complex and increasing the risk of missed prior art. Organizations traditionally chose between empowering specialized searchers with comprehensive tools or providing limited capabilities to broader teams. CAS IP Finder eliminates that compromise by providing flexible access points that connect users of all experience levels to curated content and precise search tools. "As scientific and patent data grow in complexity, organizations need IP search solutions that enable access across entire teams," said Manuel Guzman, Pres
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom